NRX Pharmaceuticals, Inc. NRXP US Equity

Health Care · CIK 1719406 · FY ends Dec 31

$3.55

-0.07 (-1.93%)

USD · as of 2026-08-28 · marketstack

NRX Pharmaceuticals, Inc. (Nasdaq: NRXP), an SEC filer in Pharmaceutical Preparations, closed at $3.55, -1.9%, on 2026-08-28, with a market cap of $238M as of 2026-08-27 and a net margin of -1980.8%. Institutional ownership, earnings history and filed financials are on the tabs below.

Switch Ticker

Short interest· FINRA consolidated · settlement 2026-08-14

6 settlement cycles

Shares short

8.7M

% of shares out

13.2%

Days to cover

5.8

Δ vs 2026-07-31

+32.4%

bars = shares short · line = days to cover (own scale)

Settlement	Shares short	Δ vs prior	Avg daily volume	Days to cover
2026-08-14	8,673,787	+32.4%	1,500,713	5.8
2026-07-31	6,552,631	+5.7%	863,825	7.6
2026-07-15	6,198,384	+14.9%	838,061	7.4
2026-06-30	5,396,019	-5.5%	1,007,329	5.4
2026-06-15	5,710,125	+14.8%	1,715,428	3.3
2026-05-29	4,975,572	+6.5%	1,647,375	3.0

FINRA Rule 4560 · twice monthly, published ~a week later.

most-shorted stocks →data sources →institutional holders (OWN) →

Output of a disclosed model — assumptions may be wrong. Research, not investment advice. See the Disclaimer.

NRX Pharmaceuticals, Inc. NRXP US Equity☆

Short interest· FINRA consolidated · settlement 2026-08-14

NRX Pharmaceuticals, Inc. NRXP US Equity